An efficient system for bioconjugation based on a widely applicable engineered O-glycosylation tag <subtitle>Short title: Controlled bioconjugation via O-glycan engineering</subtitle>
Bioconjugates are an important class of therapeutic molecules. To date, O-glycan-based metabolic glycoengineering has had limited use in this field, due to the complexities of the endogenous O-glycosylation pathway and the lack of an O-glycosylation consensus sequence. Here, we describe the developm...
Κύριοι συγγραφείς: | , , , , , , , , , , , , , |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
Taylor & Francis Group
2021-01-01
|
Σειρά: | mAbs |
Θέματα: | |
Διαθέσιμο Online: | https://www.tandfonline.com/doi/10.1080/19420862.2021.1992068 |